LPL Financial
CRNX

LPL Financial’s Crinetics Pharmaceuticals CRNX Stock Holding History

LPL Financial’s Portfolio CRNX Stock Details CRNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$331K Buy
8,838
+1,816
+26% +$67.5K ﹤0.01% 5371
2026
Q1 		$255K Buy
7,022
+868
+14% +$38.8K ﹤0.01% 5315
2025
Q4 		$286K Buy
+6,154
New +$274K ﹤0.01% 5179
2025
Q1 		– Sell
-6,071
Closed -$310K – 5389
2024
Q4 		$310K Buy
6,071
+1,162
+24% +$65K ﹤0.01% 4500
2024
Q3 		$251K Buy
+4,909
New +$253K ﹤0.01% 4573

Other funds holding CRNX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JT
Jupiter Topco New York $245B AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

LPL Financial's CRNX Position: Q2 2026 in Review

LPL Financial increased its Crinetics Pharmaceuticals (CRNX) stake by 26% in Q2 2026, buying an estimated $67.5K and bringing the position to 8,838 shares worth $331K. The position accounts for ﹤0.01% of the portfolio, ranked #5371.

LPL Financial first reported a position in CRNX in Q3 2024 and has held it in 5 quarters since. 267 funds tracked by Wall St. Rank hold CRNX as of Q2 2026.

  • LPL Financial held 8,838 shares of Crinetics Pharmaceuticals worth $331K as of Q2 2026.
  • LPL Financial bought 1,816 Crinetics Pharmaceuticals shares in Q2 2026, an estimated $67.5K.
  • Crinetics Pharmaceuticals made up ﹤0.01% of LPL Financial's portfolio in Q2 2026, its #5371 holding.
  • LPL Financial first reported a position in Crinetics Pharmaceuticals in Q3 2024 and has held it in 5 quarters since.
  • 267 funds tracked by Wall St. Rank held Crinetics Pharmaceuticals as of Q2 2026.

Based on LPL Financial's 13F filing for Q2 2026, filed 7 Aug 2026.